thome-110815.standard[1]

600 homers or not, Thome was already Hall-worthy

68 Comments

Jim Thome joined an elite club on Monday night when he became the eighth player in MLB history to hit 600 home runs. Now that the Minnesota Twins designated hitter has reached such a special milestone, be prepared to hear the question: “Does this make Jim Thome a Hall of Famer?”

I’ve got news for you: Thome didn’t need the milestone. He was already worthy of Cooperstown.

This has nothing to do with Thome being a good guy both with the media and in general (he’s one of the best), and it has nothing to do with his charitable contributions to society (he’s paying for all 10 of his nieces and nephews to go through college). Plenty of players give good interviews and do nice things for people.

No, this has to do with the sheer numbers and impact on the game. It has to do with quietly putting up strong statistics year after year for 21 seasons, compiling one of the most impressive power hitting resumes in baseball history.

Knock Thome, if you will, for spending the bulk of his career as a DH. After all, it’s only fair to give more credence to players who can hit and play defense. Give him demerits for striking out more than 2,400 times, for only being an All-Star five times, for never winning an MVP award or a World Series.

But then remember the 1,700 walks (eighth all time), the .403 on-base percentage (better than Rickey Henderson), and the respectable .277 batting average (better than Joe Morgan). Thome’s hulking presence might remind one of Paul Bunyan, but he was never an all-or-nothing axe-wielding hacker a la Dave Kingman or Rob Deer.

In examining the numbers, Baseball-reference says Thome’s career compares most closely to those of Frank Thomas, Sammy Sosa, Mike Schmidt, Harmon Killebrew, Mickey Mantle, Willie McCovey, and Willie Stargell. All of those players are in Cooperstown except for Thomas, who will be once he gains eligibility, and Sosa, a fellow member of the 600-homer club whose career has been tainted by a connection to steroids.

Thomas is an interesting comparison because like Thome, his career was spent mostly at DH. He was rightly feared as one of the best hitters of his era, notching three seasons with an OPS over 1.000, including the monster 1994 campaign of 1.217. Thomas’ career OPS is an impressive .974, but Thome’s is just a notch behind at .960. Thomas’ OPS+ is a whopping 156, but Thome’s is 147. The gulf between the players is not as wide as you might imagine.

As far as the steroids era, there is no way Thome can escape it. Type “steroids Thome” into Google and the search engine spits out more than 700,000 entries, some of which cite the steroids era as dampening excitement for the slugger’s march to 600 home runs. While Thome has never been connected to performance-enhancing drugs, it’s impossible for any player, particularly a power hitter, to avoid being tarnished by the era. It’s not fair, it’s just the way it is.

But until there is some evidence of cheating – remember, Thome’s name did not come up in the Mitchell Report, the BALCO scandal, or in any other PED investigation – we’ve got to take the man and his legacy at face value.

Prepare a place in Cooperstown, because Jim Thome has earned his place in the Hall.

You can follow Bob on Twitter here, or if Facebook is your thing, be his friend here.

Danny Espinosa reportedly skipped Nationals Winterfest because of Adam Eaton

WASHINGTON, DC - OCTOBER 13: Danny Espinosa #8 of the Washington Nationals celebrates after teammate Chris Heisey #14 (not pictured) hits a two run home run in the seventh inning against the Los Angeles Dodgers during game five of the National League Division Series at Nationals Park on October 13, 2016 in Washington, DC. (Photo by Rob Carr/Getty Images)
Getty Images
7 Comments

According to Jorge Castillo of the Washington Post, Nationals infielder Danny Espinosa declined to attend the team’s annual Winterfest because of his dissatisfaction with management following their trade for outfielder Adam Eaton.

A source told Castillo that Espinosa’s unhappiness stemmed from a belief that the acquisition would jeopardize his starting role in 2017. With Eaton in center field, Trea Turner will likely return to his post at shortstop, leaving Espinosa out in the cold — or, as the case may be, on the bench. The move shouldn’t come as a big surprise to Espinosa, however, as Nationals’ GM Mike Rizzo spoke to the possibility of trading the infielder or reassigning him to a utility role back in early November.

Offensively, the 29-year-old had a down year in 2016, slashing just .209/.306/.378 with 24 home runs in 601 PA. Defensively, he still profiles among the top shortstops in the National League, with eight DRS (Defensive Runs Saved) and 8.3 Def (Defensive Runs Above Average) in his seventh year with the club.

Espinosa will reach free agency after the 2017 season.

Nick Cafardo: Red Sox should deal Pomeranz, not Buchholz

BOSTON, MA - SEPTEMBER 18: Drew Pomeranz #31 of the Boston Red Sox pitches during the first inning against the New York Yankees at Fenway Park on September 18, 2016 in Boston, Massachusetts. The Red Sox won 5-4. (Photo by Rich Gagnon/Getty Images)
Getty Images
10 Comments

The Red Sox might be trying to move the wrong pitcher, according to the Boston Globe’s Nick Cafardo. Cafardo revealed that while the Sox have been trying to market right-hander Clay Buchholz, more teams would be interested in trades involving southpaw Drew Pomeranz.

The club appears reluctant to deal Pomeranz, especially because his price tag comes in at a cool $4.7 million to Buchholz’s $13.5 million in 2017. Those who have already expressed interest in the veteran hurlers, including the Twins, Mariners and Royals, also seem put off by Buchholz’s salary requirements as he enters his 32nd year.

Health could be another factor preventing teams from jumping to make trade offers, as Cafardo quotes an AL executive who believes the “medicals on both Pomeranz and Buchholz probably aren’t that great.” Neither pitcher suffered any major injuries during the 2016 season, though Pomeranz missed just over a week of play due to forearm soreness.

Pomeranz outperformed his fellow starter in 2016, pitching to a 3.32 ERA and career-best 9.8 K/9 through 170 2/3 innings with the Padres and Red Sox. He got off to an exceptionally strong start in San Diego, where his ERA dropped to 2.47 through the first half of the year before the Padres dealt him to Boston for minor league right-hander Anderson Espinoza. Buchholz, on the other hand, struggled with a 4.78 ERA and saw a decline in both his BB/9 and K/9 rates as he worked out a career-low 1.69 K/BB through 139 1/3 innings with the Sox.